Cannabis Stocks Rally Toward Best Weekly Performance Since 2024

Cannabis stocks are experiencing their strongest weekly performance in over a year, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing 12.8% and individual names posting even sharper gains. The rally reflects a confluence of factors including renewed federal rescheduling optimism, improving state-level sales data, and technical buying as short positions unwind across the sector.

The current surge marks a dramatic reversal from the sector's prolonged downturn that began in early 2021. Multi-state operators like Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis have each posted gains exceeding 15% this week, while smaller players in cultivation and ancillary services have seen even more pronounced moves. Trading volumes have spiked to levels not seen since the meme stock frenzy of 2021.

Regulatory momentum appears to be driving much of the enthusiasm. Recent comments from DEA officials suggesting movement on cannabis rescheduling have reignited investor hopes for meaningful federal reform. A shift from Schedule I to Schedule III would eliminate the punitive 280E tax provision that currently restricts business deductions for cannabis companies, potentially boosting sector-wide margins by 15-25 percentage points.

Institutional interest is also returning to the space after nearly three years of capital flight. Several hedge funds have disclosed new positions in leading MSOs, while cannabis-focused investment firms report increased inbound interest from pension funds and family offices. The sector's compressed valuations - with many operators trading below 1x revenue despite profitable operations - have created compelling risk-reward dynamics for contrarian investors.

The sustainability of this rally hinges on concrete regulatory progress and continued operational improvements across the industry. While current momentum is strong, cannabis stocks remain highly volatile and sensitive to policy developments. The sector's ability to maintain these gains will depend on companies demonstrating consistent profitability and cash generation while navigating an evolving regulatory landscape that still presents significant federal-state conflicts.